Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
CalciMedica Shares Plunge After Discontinuing Phase II AKI Study
Jan 29 2026
•
By
Sushmita Panda
Acute kidney injury (AKI) is a sudden decline in kidney function, impairing the organ’s ability to filter and cleanse the blood.
(Shutterstock)
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Clinical Trials
More from Scrip